TARRYTOWN, N.Y. — November 3, 2025 — Leads & Copy — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation in several healthcare conferences.
Management will participate in the Jefferies London Healthcare Conference on November 17, 2025, at 3:30 p.m. GMT (10:30 a.m. ET); the 7th Annual Wolfe Research Healthcare Conference on November 17, 2025, at 9:20 a.m. ET; the 8th Annual Evercore Healthcare Conference on December 2, 2025, at 1:20 p.m. ET; and the Citi 2025 Global Healthcare Conference on December 3, 2025, at 10:30 a.m. ET.
The sessions may be accessed from the “Investors & Media” page of Regeneron’s website. Replays and transcripts will be archived on the Company’s website for at least 30 days.
Regeneron (NASDAQ: REGN) is a biotechnology company that invents, develops, and commercializes medicines for serious diseases. Regeneron uses technologies such as VelociSuite® and the Regeneron Genetics Center®.
Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com
Source: Regeneron
